(Q30426094)

English

Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

James M McCaw

2

0 references

object named as

Jodie McVernon

1

0 references

author name string

Terence M Nolan

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Australian and New Zealand Journal of Public Health

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

113-119

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Social contacts and mixing patterns relevant to the spread of infectious diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Model-consistent estimation of the basic reproduction number from the incidence of an emerging infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Early administration of oral oseltamivir increases the benefits of influenza treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Strategies for mitigating an influenza pandemic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Mitigation strategies for pandemic influenza in the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Vaccines and their impact on the control of disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Superspreading and the effect of individual variation on disease emergence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Large-scale spatial-transmission models of infectious disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

When individual behaviour matters: homogeneous and network models in epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Antiviral resistance and the control of pandemic influenza

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-6405.2010.00493.X

21 January 2018

Identifiers

10.1111/J.1753-6405.2010.00493.X

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30426094&oldid=1606192899"